Utility of iPSC-derived cells for disease modeling, drug development, and cell therapy

MW Nicholson, CY Ting, DZH Chan, YC Cheng… - Cells, 2022 - mdpi.com
The advent of induced pluripotent stem cells (iPSCs) has advanced our understanding of the
molecular mechanisms of human disease, drug discovery, and regenerative medicine. As …

Repurposing drugs to treat cardiovascular disease in the era of precision medicine

M Abdelsayed, EJ Kort, S Jovinge… - Nature Reviews …, 2022 - nature.com
Drug repurposing is the use of a given therapeutic agent for indications other than that for
which it was originally designed or intended. The concept is appealing because of …

[HTML][HTML] Synergistic FRET assays for drug discovery targeting RyR2 channels

RT Rebbeck, KS Ginsburg, CY Ko, A Fasoli… - Journal of molecular and …, 2022 - Elsevier
A key therapeutic target for heart failure and arrhythmia is the deleterious leak through
sarcoplasmic reticulum (SR) ryanodine receptor 2 (RyR2) calcium release channels. We …

Understanding genomic medicine for thoracic aortic disease through the lens of induced pluripotent stem cells

AA Singh, DK Shetty, AG Jacob, S Bayraktar… - Frontiers in …, 2024 - frontiersin.org
Thoracic aortic disease (TAD) is often silent until a life-threatening complication occurs.
However, genetic information can inform both identification and treatment at an early stage …

Human‐induced pluripotent stem cell‐derived cardiomyocytes: Cardiovascular properties and metabolism and pharmacokinetics of deuterated mexiletine analogs

J Gomez‐Galeno, K Okolotowicz… - Pharmacology …, 2021 - Wiley Online Library
Prolongation of the cardiac action potential (AP) and early after depolarizations (EADs) are
electrical anomalies of cardiomyocytes that can lead to lethal arrhythmias and are potential …

Deciphering common long QT syndrome using CRISPR/Cas9 in Human-induced pluripotent stem cell-derived cardiomyocytes

Y Song, Z Zheng, J Lian - Frontiers in cardiovascular medicine, 2022 - frontiersin.org
From carrying potentially pathogenic genes to severe clinical phenotypes, the basic
research in the inherited cardiac ion channel disease such as long QT syndrome (LQTS) …

[PDF][PDF] Reengineering Mexiletine by chemical synthesis to decrease toxicity and improve pharmacological properties with patient-derived iPSC cardiomyocytes. Arch

JR Cashman - Clin. Toxicol, 2022 - probiologists.com
Heart disease is one of the top causes of healthcare expenses in the United States. Lethal
ventricular cardiac arrhythmia can arise in acquired or congenital heart disease. Long QT …

Atrial Fibrillation Genomics: Discovery and Translation

DH Yoo, R Bodmer, K Ocorr, CJ Larson… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review Our understanding of the fundamental cellular and molecular
factors leading to atrial fibrillation (AF) remains stagnant despite significant advancement in …